Eigil Kjeldsen. (2018) A Novel Acquired t(2;4)(q36.1;q24) with a Concurrent Submicroscopic del(4)(q23q24) in An Adult with Polycythemia Vera. Cancers 10:7, pages 214.
Crossref
Elizabeth L. Courville, Charanjeet Singh, Sophia Yohe, Michael A. Linden, Kaveh Naemi, Michael Berger, Celalettin Ustun, Robert W. McKenna & Michelle Dolan. (2016) Patients With a History of Chemotherapy and Isolated del(20q) With Minimal Myelodysplasia Have an Indolent Course. American Journal of Clinical Pathology 145:4, pages 459-466.
Crossref
Robert Peter Gale, John M. Bennett & F. Owen Hoffman. (2014) Therapy-related AML: A slip of the lip can sink a ship. Leukemia Research 38:3, pages 418-420.
Crossref
Rashmi Kanagal-Shamanna, C. Cameron Yin, Roberto N. Miranda, Carlos E. Bueso-Ramos, Xiaohong Iris Wang, Ramya Muddasani, L. Jeffrey Medeiros & Gary Lu. (2013) Therapy-related myeloid neoplasms with isolated del(20q): comparison with cases of de novo myelodysplastic syndrome with del(20q). Cancer Genetics 206:1-2, pages 42-46.
Crossref
N Mauritzson, M Albin, L Rylander, R Billström, T Ahlgren, Z Mikoczy, J Björk, U Strömberg, PG Nilsson, F Mitelman, L Hagmar & B Johansson. (2002) Pooled analysis of clinical and cytogenetic features in treatment-related and de novo adult acute myeloid leukemia and myelodysplastic syndromes based on a consecutive series of 761 patients analyzed 1976–1993 and on 5098 unselected cases reported in the literature 1974–2001. Leukemia 16:12, pages 2366-2378.
Crossref
Theo de Witte, Margriet Oosterveld, Bart Span, Petra Muus & Anton Schattenberg. (2002)
S
TEM
C
ELL
T
RANSPLANTATION
FOR
L
EUKEMIAS
F
OLLOWING
M
YELODYSPLASTIC
S
YNDROMES
OR
S
ECONDARY
TO
C
YTOTOXIC
T
HERAPY
. Reviews in Clinical and Experimental Hematology 6:1, pages 72-85.
Crossref
T. De Witte, S. Suciu, G. Verhoef, B. Labar, E. Archimbaud, C. Aul, D. Selleslag, A. Ferrant, P. Wijermans, F. Mandelli, S. Amadori, U. Jehn, P. Muus, H. Demuynck, M. Dardenne, R. Zittoun, R. Willemze, A. Gratwohl & J. Apperley. 2001. Acute Leukemias VIII. Acute Leukemias VIII
649
654
.
J. Harbott, I. Reinisch, J. Ritterbach, U. Creutzig, W.-D. Ludwig, P. Gutjahr, A. Borkhardt & F. Lampert. 1997. Acute Leukemias VI. Acute Leukemias VI
24
28
.
Flora E. Van Leeuwen. (1996) 4 Risk of acute myelogenous leukaemia and myelodysplasia following cancer treatment. Baillière's Clinical Haematology 9:1, pages 57-85.
Crossref
T. De Witte. (1994) New treatment approaches for myelodysplastic syndrome and secondary leukaemias. Annals of Oncology 5:5, pages 401-408.
Crossref
H Walker, F.J Smith & D.R Betts. (1994) Cytogenetics in acute myeloid leukaemia. Blood Reviews 8:1, pages 30-36.
Crossref
L. Detourmignies, S. Castaigne, A. M. Stoppa, J. L. Harousseau, A. Sadoun, M. Janvier, J. L. Demory, M. Sanz, R. Berger, F. Bauters, C. Chomienne & P. Fenaux. 1994. Acute Leukemias IV. Acute Leukemias IV
609
610
.
T. De Witte & A. Gratwohl. (2008) BONE MARROW TRANSPLANTATION FOR MYELODYSPLASTIC SYNDROME AND SECONDARY LEUKAEMIAS. British Journal of Haematology 84:3, pages 361-364.
Crossref
Jorge Sierra, Albert Grañena, Francesc Bosch, Enric Carreras, Josep‐Maria Martí, Alvaro Urbano‐Ispizua, Montserrat Rovira & Ciril Rozman. (2007) Mitoxantrone and intermediate‐dose cytosine arabinoside for poor‐risk acute leukemias: Response to treatment and factors influencing outcome. Hematological Oncology 10:6, pages 301-309.
Crossref
E. Auxenfants, P. Morel, J. L. Lai, C. Sartiaux, L. Detourmignies, F. Bauters & P. Fenaux. (1992) Secondary acute lymphoblastic leukemia with t (4; 11): Report on two cases and review of the literature. Annals of Hematology 65:3, pages 143-146.
Crossref